Tuesday 12 November at 3pm
Building on the success of the previous session we hosted in August, we are excited to welcome back Releaf for a follow-up presentation. Whether you attended the previous session or are joining us for the first time, this is a valuable opportunity to gain further insight into how medical cannabis can play a role in managing symptoms and improving quality of life for those with multiple sclerosis (MS).
In this session, Releaf will revisit their comprehensive overview of medical cannabis and its potential benefits for individuals living with MS. There will also be an explanation of the services and support they offer to help MS patients exploring medical cannabis as part of a treatment plan.
Nearly three-quarters of people with MS experience spasticity and over half experience chronic pain. These debilitating symptoms can severely impact daily life and overall wellbeing. However, both symptoms have been shown to have positive responses to cannabis-based treatments.
Releaf is one of the UK’s leading all-in-one medical cannabis service, providing safe and legal access to cannabis-based options. In the session we will hear from the Releaf team, sharing the remarkable success they have seen in treating individuals with MS-related symptoms including severe muscle spasms, joint pain and poor sleep. We will also discover how they safely and seamlessly, incorporate medical cannabis into MS treatment plans.
Join us for our information session on Tuesday 12 November at 3pm, with Dr Michal, Consultant Neurologist and Charlene Rowe, Head of Patient Engagement and Support.
You can find more information on this topic of cannabis by viewing our resource on Cannabis and MS. It provides an introduction to cannabis including its use and research behind its benefits, plus the products that are available.
To find out more about medical cannabis including how it is prescribed and its benefits for people with MS, please see our blog.
Dr Michal Modestowicz has dedicated his career to the treatment of neurological conditions, including headaches, migraines, multiple sclerosis, polyneuropathy, Parkinson’s disease, dementia, and tics. Joining Releaf as a Consultant Neurologist in April 2024, Dr Michal Modestowicz brings more than a decade of experience in neurology plus two years within the medicinal cannabis industry to Releaf patients.’
Charlene Rowe has over four years of experience in the Medical Cannabis industry, serves as the Head of Patient Engagement and Support at Releaf. In her role, Charlene leads the Patient Support and Operations Team with dedication and compassion, ensuring that every patient receives the comprehensive support they need throughout their healthcare journey. Her commitment to patient care and her expertise in managing support services have made her an invaluable asset to Releaf, where she continuously strives to enhance the patient experience at every step.
To join this session, please login or register in our Portal area. The session is free to join if you have a monthly or year subscription. You do not need a subscription to join, as you can register and provide a donation for the class. The suggested amount for the class is £5. If you unable to make a donation, please contact us to see how you can access the online classes.
If you would like to know more or you are having trouble registering, please contact us at register@ms-uk.org.
